Format

Send to

Choose Destination
Lancet Oncol. 2015 Jul;16(7):e311. doi: 10.1016/S1470-2045(15)00065-0.

Nilotinib versus imatinib for GIST.

Author information

1
Gustave Roussy Cancer Campus, Villejuif, France.
2
University Paris Descartes Cochin Teaching Hospital, Paris, France.
3
University Paris Descartes INSERM CIC1419, Paris, France.
4
Gustave Roussy Cancer Campus, Villejuif, France; University Paris Descartes INSERM CIC1419, Paris, France. Electronic address: olivier.mir@gustaveroussy.fr.
PMID:
26149879
DOI:
10.1016/S1470-2045(15)00065-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center